Document is current
Any future updates will be listed below
-
Authors
Ng, Cheoklong
Jing, Taile
Yu, Shicheng
Ye, Jianjun
Zhang, Shun
Jia, Zhankui
Tang, Qi
Hu, Xiaoyi
Chen, Minfeng
Huang, Weiping
Wu, Jitao
Bi, Hai
Yan, Zejun
Shen, Haibo
Xiong, Wei
Liu, Zheng
Xiao, Jun
Zhang, Tao
Wei, Xuedong
Hu, Hailong
Yang, Qing
Yuan, Yichu
Huang, Zhiyang
Xue, Wei
Bao, Yige
Ding, Guoqing
Xia, Dan
Huang, Jiwei
-
Funding
Funding for this research was provided by:
Science and Technology Commission of Shanghai Municipality (24ZR1492000)
Shanghai Municipal Health Commission (2023ZZ02014)
Beijing Xisike Clinical Oncology Research Foundation (Y-Gilead2024-PT-0054)
National Natural Science Foundation of China (82102748)
Wu Jieping Medical Foundation (320.6750.2022-19-92)
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 18 August 2025
First Online: 13 September 2025
Declarations
:
: All authors have no relevant financial or non-financial interests to disclose.
: The study was approved by the Ethics Committee of Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine (approval number: KY2024-109-C). Due to the retrospective nature of the study, the requirement for obtaining informed consent was waived by the Ethical Committee of Shanghai Jiao Tong University School of Medicine affiliated Renji hospital. This study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
: Informed consent was obtained from all individual participants included in the study.
